Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing a new class of breakthrough medicines for inflammatory and proliferative diseases
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing a new class of breakthrough medicines for inflammatory and proliferative diseases. The company focuses on developing novel, oral small molecule therapies targeting STAT3.